Improvement of spontaneous speech in early stage Alzheimer’s disease with rivastigmine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improvement of spontaneous speech in early stage Alzheimer’s disease with rivastigmine

Published:2009-01 Issue:1 Volume:13 Page:34-38
ISSN:1279-7707
Container-title:The Journal of Nutrition, Health and Aging
language:en
Short-container-title:J Nutr Health Aging

Author:

Visch-Brink E. G.,Rhee-Temme W.,Rietveld T.,Krulder J. W. M.,Harskamp F.,Cammen T. J. M.

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s12603-009-0007-z.pdf

Reference51 articles.

1. Birks J. Cholinesterase inhibitors for Alzheimer’s disease (review). Cochrane Library 2007, issue 3.

2. Kurz A, Farlow M, Quarg P, Spiegel R. Disease stage in Alzheimer’s disease and treatment effects of rivastigmine. Alzheimer Dis Assoc Disord 2004;3:123–128.

3. Farlow M, Anand R, Messina J, Hartman R, Veach J. A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer’s disease. Eur Neurol 2000;44:236–241.

4. Almkvist O, Darreh-Shon T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer’s disease in comparison with untreated AD and MCI patients. Eur J neurol 2004, 11, 253–261.

5. Seltzer B. Cholinesterase inhibitors in the clinical management of Alzheimer’s disease: importance of early and persistent treatment. J Int Med Res 2006;34:339–347.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we track the progression of Alzheimer's Disease via lexical-semantic variables in connected speech?;Journal of Neurolinguistics;2024-05

2. Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System;CNS Drugs;2023-06-21

3. Connected Speech in Neurodegenerative Language Disorders: A Review;Frontiers in Psychology;2017-03-06

4. Need for and Challenges Facing Functional Communication as Outcome Parameter in AD Clinical Trials;Alzheimer Disease & Associated Disorders;2013-10

5. Aspects of communication in Alzheimer's disease: clinical features and treatment options;International Psychogeriatrics;2013-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3